Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Reem AlJabari"'
Autor:
Yacoub A. Yousef, Qusai F. Abu Salim, Mona Mohammad, Imad Jaradat, Mustafa Mehyar, Reem AlJabari, Omar Al-Habahbeh, Khalid Saboubeh, Hadeel Halalsheh, Jakub Khzouz, Munir Shawagfeh, Iyad Sultan, Mahmoud AlMasri, Ibrahim Al-Nawaiseh, Maysa Al-Hussaini, Asem Mansour
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
PurposeThe humanitarian crisis in Syria has had a profound impact on the entire region. In this study, we report the patterns of presentation and management outcomes of Syrian patients with Retinoblastoma (Rb) treated at a single tertiary cancer cent
Externí odkaz:
https://doaj.org/article/663f4374c6e54333bebbb7251707ff9d
Autor:
Yacoub A Yousef, Mona Mohammad, Ibrahim AlNawaiseh, Reem AlJabari, Mario Damiano Toro, Almutez Gharaibeh, Robert Rejdak, Katarzyna Nowomiejska, Sandrine Zweifel, Teresio Avitabile, Magdalena Rejdak, Rashed Nazzal
Publikováno v:
Clinical Ophthalmology, Vol Volume 16, Pp 101-109 (2022)
Clinical Ophthalmology (Auckland, N.Z.)
Clinical Ophthalmology (Auckland, N.Z.)
Yacoub A Yousef,1 Mona Mohammad,1 Ibrahim AlNawaiseh,1 Reem AlJabari,1 Mario Damiano Toro,2,3 Almutez Gharaibeh,4 Robert Rejdak,5 Katarzyna Nowomiejska,5 Sandrine Zweifel,3 Teresio Avitabile,6 Magdalena Rejdak,6 Rashed Nazzal2 1Department of Surgery
Autor:
Yacoub A. Yousef, Mona Mohammad, Ibrahim Al-Nawaiseh, Hala Mahafza, Hadeel Halalsheh, Mustafa Mehyar, Reem AlJabari, Khaleel Al-Rawashdeh, Imad Jaradat, Iyad Sultan, Maysa Al-Hussaini
Publikováno v:
Ophthalmic genetics.
We present an epidemiologic analysis of retinoblastoma (RB) and uveal melanoma (UM) in Jordan to aid national strategies for improved ocular cancer surveillance and control.A retrospective cohort of all Jordanian patients with RB and UM diagnosed ove
Autor:
Reem AlJabari, Ibrahim Qaddoumi, Nakhleh E. Abu-Yaghi, Iyad Sultan, Mustafa Mehyar, Ibrahim Al-Nawaiseh, Mona Mohammad, Matthew W. Wilson, Yacoub A. Yousef, Carlos Rodriguez-Galindo, Maysa Al-Hussaini, Imad Jaradat
Publikováno v:
Ophthalmology. 128:130-137
Objective To evaluate the efficacy of integrating telemedicine-based twinning partnership and centralized care for Retinoblastoma (RB) on survival and eye salvage. Design A cohort of 478 RB patients from 2003 to 2019 treated at tertiary referral canc
Autor:
Ibrahim Al-Nawaiseh, Imad Jaradat, Mohammad Mosallam, Reem AlJabari, Abdelghani Tbakhi, Ala Saab, Iyad Sultan, Maysa Al-Hussaini, Mustafa Mehyar, Mona Mohammad, Yacoub A. Yousef, Rasha Deebajah
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 3, Pp 152-159 (2020)
Objective/background Retinoblastoma (RB), the most common intraocular malignancy in children, is caused by biallelic inactivation of the human retinoblastoma susceptibility gene (RB1). We are evaluating the impact of the type of RB1 gene mutation on
Publikováno v:
Ophthalmic Genetics. 40:191-195
Background: Early diagnosis and timely management of Retinoblastoma (RB) patients are essential to improve eye salvage and survival rates. The objective of this study is to evaluate the lev...
Autor:
Mays AlJboor, Hadeel Halalsheh, Maysa Al-Hussaini, Iyad Sultan, Ibrahim Al-Nawaiseh, Munir Shawagfeh, Abdelrahman Alkhoms, Maha Lahlouh, Imad Jaradat, Mona Mohammad, Yacoub A. Yousef, Rasha Deebajah, Reem AlJabari, Mustafa Mehyar
Publikováno v:
Ophthalmic genetics. 41(4)
To study the impact of a Retinoblastoma (Rb) screening program in the absence of genetic testing on the management and outcome of high-risk children.This is a retrospective, clinical case series of 76 children from families involved in a Rb screening
Autor:
Yacoub A, Yousef, Ibrahim, Al-Nawaiseh, Mustafa, Mehyar, Iyad, Sultan, Maysa, Al-Hussaini, Imad, Jaradat, Mona, Mohammad, Reem, AlJabari, Nakhleh, Abu-Yaghi, Carlos, Rodriguez-Galindo, Ibrahim, Qaddoumi, Matthew, Wilson
Publikováno v:
Ophthalmology. 128(1)
To evaluate the efficacy of integrating a telemedicine-based twinning partnership and centralized care for retinoblastoma on survival and eye salvage.Four hundred seventy-eight retinoblastoma patients treated at a tertiary referral cancer center (Kin